These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8431656)

  • 1. Prestorage leukocyte depletion of blood products in a closed system.
    Pietersz RN; Steneker I; Reesink HW
    Transfus Med Rev; 1993 Jan; 7(1):17-24. PubMed ID: 8431656
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection.
    Rawal BD; Davis RE; Busch MP; Vyas GN
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):36-41. PubMed ID: 2134639
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leukocyte depletion of blood products. Indications and technical implementation].
    Böck M; Heim MU
    Fortschr Med; 1995 Mar; 113(8):102-4. PubMed ID: 7759031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prestorage leukocyte depletion is not necessarily required for the prevention of refractoriness to platelet transfusion.
    de Wolf J; Westerterp A; Smit Sibinga C; Halie MR
    Blood; 1995 Oct; 86(8):3263-4. PubMed ID: 7579424
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of blood components with ultraviolet-B irradiation.
    Pamphilon DH
    Vox Sang; 1998; 74 Suppl 2():15-9. PubMed ID: 9704422
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization.
    Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ
    Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466
    [No Abstract]   [Full Text] [Related]  

  • 7. Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets.
    Gmür J; Burger J; Sauter C; Oelz O; Frick PG
    Prog Clin Biol Res; 1990; 337():45-8. PubMed ID: 2191337
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of leukocyte-reduced blood components.
    Miller JP; Mintz PD
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allo-immunization against 5 erythrocyte antigens after transfusion exclusively of packed platelets].
    Lorriaux C; Vinatier I; Capiod JC; Bautard B; Mannessier L; Faille N
    Rev Fr Transfus Hemobiol; 1991 Oct; 34(5):409-13. PubMed ID: 1772525
    [No Abstract]   [Full Text] [Related]  

  • 10. The challenge of platelet alloimmunization: management and prevention.
    Kickler TS
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):8-18. PubMed ID: 2134640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Why remove leukocytes from labile blood products in 1995?].
    Andreu G; Belhocine R; Klaren J; Fretz C; Lejus C
    Transfus Clin Biol; 1996; 3(1):57-74. PubMed ID: 8640315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukocyte depletion, a comparison of the "Leukotrap in-line" filter system with a sterile added 4-bag Speacell-R-500-A filter system].
    Menke-Möllers I; Burrichter H; Schiene K; Grunenberg R; Krüger J
    Beitr Infusionsther; 1992; 30():152-6. PubMed ID: 1284694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Permselect--a new substance for leukocyte elimination].
    Mavrina L; Matthes G; Ehwald R
    Beitr Infusionsther; 1992; 30():157-61. PubMed ID: 1284695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloimmunization as a problem for platelet transfusion.
    Bonacossa IA
    Transfus Med Rev; 1990 Apr; 4(2):144-8. PubMed ID: 2134622
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.
    Brand A; Claas FH; Voogt PJ; Wasser MN; Eernisse JG
    Vox Sang; 1988; 54(3):160-6. PubMed ID: 3369136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of a simple hollow fiber system with leukocyte filter for production of leukocyte depleted erythrocyte concentrates and plasma].
    Schwarzfischer G; Heim MU; Böck M; Kratzer MA; Mempel W
    Beitr Infusionsther; 1992; 30():287-91. PubMed ID: 1284718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates.
    Corash L
    Vox Sang; 1998; 74 Suppl 2():173-6. PubMed ID: 9704443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral inactivation of blood components: recent advances.
    Horowitz B; Ben-Hur E
    Transfus Clin Biol; 1996; 3(1):75-7. PubMed ID: 8640317
    [No Abstract]   [Full Text] [Related]  

  • 20. Contamination control in nursing with filtration: part 2: emerging rationale for bedside (final) filtration of prestorage leukocyte-reduced blood products.
    Ortolano GA; Russell RL; Angelbeck JA; Schaffer J; Wenz B
    J Infus Nurs; 2004; 27(3):157-65. PubMed ID: 15118453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.